Literature DB >> 21730121

Distant and new mutations in CTX-M-1 beta-lactamase affect cefotaxime hydrolysis.

Francisco José Pérez-Llarena1, Frédéric Kerff, Olga Abián, Susana Mallo, María Carmen Fernández, Moreno Galleni, Javier Sancho, Germán Bou.   

Abstract

The CTX-M β-lactamases are an increasingly prevalent group of extended-spectrum β-lactamases (ESBL). Point mutations in CTX-M β-lactamases are considered critical for enhanced hydrolysis of cefotaxime. In order to clarify the structural determinants of the activity against cefotaxime in CTX-M β-lactamases, screening for random mutations was carried out to search for decreased activity against cefotaxime, with the CTX-M-1 gene as a model. Thirteen single mutants with a considerable reduction in cefotaxime MICs were selected for biochemical and stability studies. The 13 mutated genes of the CTX-M-1 β-lactamase were expressed, and the proteins were purified for kinetic studies against cephalothin and cefotaxime (as the main antibiotics). Some of the positions, such as Val103Asp, Asn104Asp, Asn106Lys, and Pro107Ser, are located in the (103)VNYN(106) loop, which had been described as important in cefotaxime hydrolysis, although this has not been experimentally confirmed. There are four mutations located close to catalytic residues-Thr71Ile, Met135Ile, Arg164His, and Asn244Asp-that may affect the positioning of these residues. We show here that some distant mutations, such as Ala219Val, are critical for cefotaxime hydrolysis and highlight the role of this loop at the top of the active site. Other distant substitutions, such as Val80Ala, Arg191, Ala247Ser, and Val260Leu, are in hydrophobic cores and may affect the dynamics and flexibility of the enzyme. We describe here, in conclusion, new residues involved in cefotaxime hydrolysis in CTX-M β-lactamases, five of which are in positions distant from the catalytic center.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21730121      PMCID: PMC3165300          DOI: 10.1128/AAC.00298-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

Review 1.  Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes.

Authors:  R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

2.  Effects of Ser130Gly and Asp240Lys substitutions in extended-spectrum beta-lactamase CTX-M-9.

Authors:  C Aumeran; C Chanal; R Labia; D Sirot; J Sirot; R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

3.  High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution.

Authors:  Monica Cartelle; Maria del Mar Tomas; Francisca Molina; Rita Moure; Rosa Villanueva; German Bou
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

4.  Characterization and amino acid sequence of the OXY-2 group beta-lactamase of pI 5.7 isolated from aztreonam-resistant Klebsiella oxytoca strain HB60.

Authors:  S Farzaneh; J Péduzzi; L Sofer; A Reynaud; M Barthélémy; R Labia
Journal:  J Antimicrob Chemother       Date:  1997-12       Impact factor: 5.790

5.  Sequence of the gene encoding a plasmid-mediated cefotaxime-hydrolyzing class A beta-lactamase (CTX-M-4): involvement of serine 237 in cephalosporin hydrolysis.

Authors:  M Gazouli; E Tzelepi; S V Sidorenko; L S Tzouvelekis
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

6.  A new plasmidic cefotaximase in a clinical isolate of Escherichia coli.

Authors:  A Bauernfeind; H Grimm; S Schweighart
Journal:  Infection       Date:  1990 Sep-Oct       Impact factor: 3.553

7.  Role of a mutation at position 167 of CTX-M-19 in ceftazidime hydrolysis.

Authors:  Soichiro Kimura; Masaji Ishiguro; Yoshikazu Ishii; Jimena Alba; Keizo Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

8.  Effect of D240G substitution in a novel ESBL CTX-M-27.

Authors:  R Bonnet; C Recule; R Baraduc; C Chanal; D Sirot; C De Champs; J Sirot
Journal:  J Antimicrob Chemother       Date:  2003-05-29       Impact factor: 5.790

9.  A novel extended-spectrum beta-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance.

Authors:  Enno Stürenburg; Alexandra Kühn; Dietrich Mack; Rainer Laufs
Journal:  J Antimicrob Chemother       Date:  2004-06-16       Impact factor: 5.790

10.  Chromosomally encoded cephalosporin-hydrolyzing beta-lactamase of Proteus vulgaris RO104 belongs to Ambler's class A.

Authors:  J Péduzzi; A Reynaud; P Baron; M Barthélémy; R Labia
Journal:  Biochim Biophys Acta       Date:  1994-07-20
View more
  14 in total

1.  The Drug-Resistant Variant P167S Expands the Substrate Profile of CTX-M β-Lactamases for Oxyimino-Cephalosporin Antibiotics by Enlarging the Active Site upon Acylation.

Authors:  Meha P Patel; Liya Hu; Vlatko Stojanoski; Banumathi Sankaran; B V Venkataram Prasad; Timothy Palzkill
Journal:  Biochemistry       Date:  2017-06-27       Impact factor: 3.162

2.  Synergistic effects of functionally distinct substitutions in β-lactamase variants shed light on the evolution of bacterial drug resistance.

Authors:  Meha P Patel; Liya Hu; Cameron A Brown; Zhizeng Sun; Carolyn J Adamski; Vlatko Stojanoski; Banumathi Sankaran; B V Venkataram Prasad; Timothy Palzkill
Journal:  J Biol Chem       Date:  2018-10-01       Impact factor: 5.157

3.  Excess positional mutual information predicts both local and allosteric mutations affecting beta lactamase drug resistance.

Authors:  George A Cortina; Peter M Kasson
Journal:  Bioinformatics       Date:  2016-07-27       Impact factor: 6.937

4.  GES-18, a new carbapenem-hydrolyzing GES-Type β-lactamase from Pseudomonas aeruginosa that contains Ile80 and Ser170 residues.

Authors:  Carine Bebrone; Pierre Bogaerts; Heinrich Delbrück; Sandra Bennink; Michaël B Kupper; Roberta Rezende de Castro; Youri Glupczynski; Kurt M Hoffmann
Journal:  Antimicrob Agents Chemother       Date:  2012-10-31       Impact factor: 5.191

5.  Functional Characterization of CTX-M-14 and CTX-M-15 β-Lactamases by In Vitro DNA Shuffling.

Authors:  Kathy Hiu Laam Po; Edward Wai Chi Chan; Sheng Chen
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

6.  Defining Substrate Specificity in the CTX-M Family: the Role of Asp240 in Ceftazidime Hydrolysis.

Authors:  Barbara Ghiglione; María Margarita Rodríguez; Lucrecia Curto; Florencia Brunetti; Milena Dropa; Robert A Bonomo; Pablo Power; Gabriel Gutkind
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

Review 7.  Predicting allostery and microbial drug resistance with molecular simulations.

Authors:  George A Cortina; Peter M Kasson
Journal:  Curr Opin Struct Biol       Date:  2018-09-19       Impact factor: 6.809

8.  Biochemical characterization of CTX-M-15 from Enterobacter cloacae and designing a novel non-β-lactam-β-lactamase inhibitor.

Authors:  Mohammad Faheem; Md Tabish Rehman; Mohd Danishuddin; Asad U Khan
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

9.  CTX-M Enzymes: Origin and Diffusion.

Authors:  Rafael Cantón; José María González-Alba; Juan Carlos Galán
Journal:  Front Microbiol       Date:  2012-04-02       Impact factor: 5.640

10.  bla CTX-M-152, a Novel Variant of CTX-M-group-25, Identified in a Study Performed on the Prevalence of Multidrug Resistance among Natural Inhabitants of River Yamuna, India.

Authors:  Mudsser Azam; Arif T Jan; Qazi M R Haq
Journal:  Front Microbiol       Date:  2016-02-23       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.